肺动脉高压：从基础科学到转化方法的新见解和最新进展。
Pulmonary Hypertension: New Insights and Recent Advances from Basic Science to Translational Approaches.
机构信息
Universities of Giessen and Marburg Lung Center (UGMLC), Excellence Cluster Cardio-Pulmonary Institute (CPI), Member of the German Center for Lung Research (DZL), Justus-Liebig University, 35392 Giessen, Germany.
出版信息
Int J Mol Sci. 2023 May 9;24(10):8462. doi: 10.3390/ijms24108462.
Abstract
This Special Issue, "Molecular Research on Pulmonary Hypertension 3 [...].
摘要
本期特刊主题为“肺动脉高压的分子研究 3 […].
相似文献
1
Pulmonary Hypertension: New Insights and Recent Advances from Basic Science to Translational Approaches.肺动脉高压：从基础科学到转化方法的新见解和最新进展。
Int J Mol Sci. 2023 May 9;24(10):8462. doi: 10.3390/ijms24108462.
2
Translational Advances in the Field of Pulmonary Hypertension Molecular Medicine of Pulmonary Arterial Hypertension. From Population Genetics to Precision Medicine and Gene Editing.肺动脉高压领域的转化进展 肺动脉高压的分子医学。从群体遗传学到精准医学和基因编辑。
Am J Respir Crit Care Med. 2017 Jan 1;195(1):23-31. doi: 10.1164/rccm.201605-0905PP.
3
Translational Advances in the Field of Pulmonary Hypertension Bench to Bedside: How Fundamental Discoveries in Science Are Advancing Our Understanding and Therapy of Pulmonary Arterial Hypertension.肺动脉高压领域的转化进展：从 bench 到 bedside——科学领域的基础发现如何推动我们对肺动脉高压的理解与治疗
Am J Respir Crit Care Med. 2017 Jan 1;195(1):1-3. doi: 10.1164/rccm.201608-1637ED.
4
Translational Advances in the Field of Pulmonary Hypertension. From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling Hubs.肺动脉高压领域的转化研究进展。从癌症生物学到新的肺动脉高压治疗方法。靶向细胞生长和增殖信号枢纽。
Am J Respir Crit Care Med. 2017 Feb 15;195(4):425-437. doi: 10.1164/rccm.201606-1226PP.
5
Emerging concepts and translational priorities in pulmonary arterial hypertension.肺动脉高压的新兴概念与转化研究重点
Circulation. 2008 Sep 30;118(14):1486-95. doi: 10.1161/CIRCULATIONAHA.106.673988.
6
Cell-Based Gene Therapy in Pulmonary Arterial Hypertension: Journeys in Translational Medicine.基于细胞的基因疗法治疗肺动脉高压：转化医学之旅。
Circ Res. 2015 Sep 11;117(7):596-8. doi: 10.1161/CIRCRESAHA.115.307247.
7
Novel molecular insights and public omics data in pulmonary hypertension.肺动脉高压的新分子见解和公共组学数据。
Biochim Biophys Acta Mol Basis Dis. 2021 Oct 1;1867(10):166200. doi: 10.1016/j.bbadis.2021.166200. Epub 2021 Jun 16.
8
Treatment of pulmonary hypertension: bench to bedside.肺动脉高压的治疗：从基础到临床。
Respir Med. 2011 Oct;105 Suppl 1:S7-11. doi: 10.1016/S0954-6111(11)70004-X.
9
Basic and translational science advances in congenital diaphragmatic hernia.先天性膈疝的基础和转化科学进展。
Semin Perinatol. 2020 Feb;44(1):151170. doi: 10.1053/j.semperi.2019.07.009. Epub 2019 Jul 30.
10
Seeking the right targets: gene therapy advances in pulmonary arterial hypertension.寻找正确的靶点：肺动脉高压的基因治疗进展
Eur Respir J. 2012 Feb;39(2):235-7. doi: 10.1183/09031936.00190011.
引用本文的文献
1
Therapeutic Approaches in Pulmonary Arterial Hypertension with Beneficial Effects on Right Ventricular Function-Preclinical Studies.肺动脉高压治疗方法对右心室功能有益的影响-临床前研究。
Int J Mol Sci. 2023 Oct 24;24(21):15539. doi: 10.3390/ijms242115539.
2
The Impact of Abnormal Lipid Metabolism on the Occurrence Risk of Idiopathic Pulmonary Arterial Hypertension.异常脂质代谢对特发性肺动脉高压发病风险的影响。
Int J Mol Sci. 2023 Sep 19;24(18):14280. doi: 10.3390/ijms241814280.
3
Metabolomics in Pulmonary Hypertension-A Useful Tool to Provide Insights into the Dark Side of a Tricky Pathology.代谢组学在肺动脉高压中的应用——揭示棘手病理黑暗面的有用工具。
Int J Mol Sci. 2023 Aug 25;24(17):13227. doi: 10.3390/ijms241713227.
4
Allicin, an Emerging Treatment for Pulmonary Arterial Hypertension: An Experimental Study.大蒜素治疗肺动脉高压的实验研究。
Int J Mol Sci. 2023 Aug 19;24(16):12959. doi: 10.3390/ijms241612959.
本文引用的文献
1
Peripheral Blood T Cells of Patients with IPAH Have a Reduced Cytokine-Producing Capacity.特发性肺动脉高压患者的外周血 T 细胞产生细胞因子的能力降低。
Int J Mol Sci. 2022 Jun 10;23(12):6508. doi: 10.3390/ijms23126508.
2
An Ovine Model for Percutaneous Pulmonary Artery Laser Denervation: Perivascular Innervation and Ablation Lesion Characteristics.经皮肺动脉激光去神经支配的绵羊模型：血管周围神经支配及消融损伤特征
Int J Mol Sci. 2021 Aug 16;22(16):8788. doi: 10.3390/ijms22168788.
3
Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension.可溶性晚期糖基化终产物受体（sRAGE）是人类肺动脉高压的敏感生物标志物。
Int J Mol Sci. 2021 Aug 10;22(16):8591. doi: 10.3390/ijms22168591.
4
KCNK3 Mutation Causes Altered Immune Function in Pulmonary Arterial Hypertension Patients and Mouse Models.KCNK3 突变导致肺动脉高压患者和小鼠模型的免疫功能改变。
Int J Mol Sci. 2021 May 9;22(9):5014. doi: 10.3390/ijms22095014.
5
Mechanisms Contributing to the Dysregulation of miRNA-124 in Pulmonary Hypertension.导致肺动脉高压中 miRNA-124 失调的机制。
Int J Mol Sci. 2021 Apr 8;22(8):3852. doi: 10.3390/ijms22083852.
6
Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension.三氟拉嗪治疗肺动脉高压的新型治疗药物的临床前研究。
Int J Mol Sci. 2021 Mar 13;22(6):2919. doi: 10.3390/ijms22062919.
7
Implication of EZH2 in the Pro-Proliferative and Apoptosis-Resistant Phenotype of Pulmonary Artery Smooth Muscle Cells in PAH: A Transcriptomic and Proteomic Approach.EZH2 在肺动脉平滑肌细胞增殖和抗凋亡表型中的作用：一种转录组学和蛋白质组学方法。
Int J Mol Sci. 2021 Mar 15;22(6):2957. doi: 10.3390/ijms22062957.
Zotero 插件